Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001359820-11-000003

CEO bought 5,000 shares at $1.05 ($5,250)

From the SEC's structured data for this filing

Trades in this filing

Babcock Dwight William · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2011-03-15 Purchase : show line 1 in the form +5,000 $1.05 $5,250 161,273 D
Open-market purchases · 5,000 sh · avg $1.05 · $5,250
Loading xslF345X03/primary_doc.xml…